Skip to main content
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Main navigation - Mobile
Innovative OTC Remedies for Seasonal Flu Epidemic
Critical Steps for a Successful Drug Product Tech Transfer
Catalent commences $200M investment in Wisconsin, Indiana
Tuesday, January 8, 2019
Catalent plans $200 million investment to expand its drug manufacturing and drug product fill/finish at two plants.
Catalent is expanding and adding jobs at Indiana biologics plant
Thursday, December 6, 2018
CDMO Catalent is adding packaging equipment to the biologics plant in Indiana it picked up last year in a $950 million deal.
Catalent invests in China—News of Note
Tuesday, November 13, 2018
Abzena will invest $20 million in a cell manufacturing facility, and Catalent is spending $2.5 million on a clinical supply facility in China.
Catalent upgrades Italy plant—News of Note
Tuesday, October 9, 2018
Here is some news of note for the week.
Value Creation in the Early Phase
Catalent’s Cook Pharmica slapped with a Form 483 by FDA
Thursday, September 13, 2018
Cook Pharmica, a biologics manufacturing company Catalent bought last year, was hit with a Form 483 by the FDA.
Catalent lays out $133M for Juniper Pharmaceuticals
Tuesday, July 3, 2018
CDMO Catalent will pay about $133 million for Boston-based Juniper Pharmaceuticals.
Allergan gets new CFO to help deal with financial hurdles
Monday, February 5, 2018
Allergan, which is maneuvering through a host of financial challenges, has landed a new CFO who can help figure out how to pay for the fixes.